Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas
Clinical trial NCT03262116 · TERMINATED
Trial details
- NCT number
- NCT03262116
- Sponsor
- Massachusetts General Hospital
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-19
- Primary completion
- 2019-07-23
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.